LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.66 USD -2.35% Market Closed
Market Cap: 43.6m USD
Have any thoughts about
LAVA Therapeutics NV?
Write Note

LAVA Therapeutics NV
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

LAVA Therapeutics NV
Long-Term Debt Peer Comparison

Comparables:
PHARM
PRQR
QURE
ARGX
MRUS

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Long-Term Debt
$591k
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Long-Term Debt
$166.1m
CAGR 3-Years
5%
CAGR 5-Years
41%
CAGR 10-Years
64%
ProQR Therapeutics NV
NASDAQ:PRQR
Long-Term Debt
€13.1m
CAGR 3-Years
-26%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Long-Term Debt
$477.8m
CAGR 3-Years
88%
CAGR 5-Years
68%
CAGR 10-Years
37%
argenx SE
XBRU:ARGX
Long-Term Debt
$28.1m
CAGR 3-Years
85%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is LAVA Therapeutics NV's Long-Term Debt?
Long-Term Debt
591k USD

Based on the financial report for Dec 31, 2023, LAVA Therapeutics NV's Long-Term Debt amounts to 591k USD.

What is LAVA Therapeutics NV's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
-47%

Over the last year, the Long-Term Debt growth was 48%. The average annual Long-Term Debt growth rates for LAVA Therapeutics NV have been -47% over the past three years .

Back to Top